Kristina Rother is an Endocrinology/Metabolic physician affiliated with National Institutes of Health. OpenAlex indexes 174 publications with 11,225 citations (h-index 53); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Pediatric Endocrinology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9000 Rockville Pike Bldg 10
Bethesda, MD 208920001
Telephone
301-435-4639Registry record last updated 14 Sept 2015.
Clinical trials
- Effects of Caloric Restriction Alone Versus Postoperative Caloric Restriction Following Bariatric Surgery on Glucose Metabolism in Patients With Diabetes Mellitus
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks
The Lancet Diabetes & Endocrinology
2019 - Maternal Exposure to Non-nutritive Sweeteners Impacts Progeny’s Metabolism and Microbiome
Frontiers in Microbiology
2019 - JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
Journal of Clinical Investigation
2018 - Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum
Genetics in Medicine
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Edward Lakatta, MD
National Institutes of Health
Douglas Lowy, MD
National Institutes of Health
Jerome Fleg, MD
National Institutes of Health
Robert Star, MD
National Institutes of Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”